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Dear Editor,
It was with great interest that we read the letter by Cal-
lender et al. [1], describing the use of thromboelastography
(TEG) and thromboelastography platelet mapping (TEG-
PM) in patients undergoing hip replacements whilst still on
antiplatelet medication.
TEG is a highly efficient system for discerning clotting
abnormalities in a setting where time is of the upmost
importance [2]. The many disciplines involved in the
management of the acute cardiac surgical patient, including
perfusionists and anaesthetists, have a high appreciation of
the device [3].
There is little point in having a screening test, as in the
case of TEG-PM, without a treatment strategy in place. If a
patient was found to have significant inhibition of their
platelets, what does one do? One strategy would be to wait
until the clotting function normalised, and this would be
appropriate in the case of elective cases where antiplatelet
treatment can be stopped a few days prior. Callender’s
letter was itself a response to Hossain et al. [4] describing
patients on antiplatelet therapy who were undergoing repair
of hip fractures. Hip fractures require urgent surgery but
one can argue that in patients that are stable, the operation
can be delayed until platelet function normalises after
discontinuation of anti-platelet medication. Hossain et al.
have also shown that these patients may not be at an
increased risk of bleeding anyway.
However, what happens in the case of emergencies as in
the scenario of significant trauma? Our experience is
somewhat peculiar in this regard.
We in cardiac surgery have developed a protocol of
giving platelets prophylactically during the operation in
patients with more than 70 % platelet inhibition and where
surgery cannot wait.
It is a bold move to make given that platelet transfusion
is not without its risk and is certainly not cheap.
However, recent evidence shows that there is little
negative impact in giving platelets peri-operatively in
patients with a high platelet inhibition on TEG-PM. In fact,
it improves the clotting profile very quickly [5]. Despite
this, the results for the impact on post-operative bleeding
and product transfusion are still pending.
Hence, TEG-PM has the potential to be a very nifty rapid
analysis tool not only for predicting surgical patients at an
increased risk of bleeding, as in the case of patients on
antiplatelet therapy, but also to implicate a treatment strategy
in urgent patients. To err on the side of caution, however,
there must be a greater impetus on randomised clinical trials
of such a treatment strategy across all modalities of surgery,
including orthopaedics and trauma, since the physiology and
clotting changes that occur during cardiac surgery do not
necessarily occur during general orthopaedic surgery.
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